Physician profile
Halley Donlin
NPI 1548991540
$548.93
in general payments reported to CMS, 2019-2025
13 companies · $257 in 2025
The $257 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $31.56 · 2023: $131 · 2024: $130 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $517.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $138.87 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $96.07 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $47.62 | 2022-2025 | Capvaxive, Gardasil 9 |
| Seqirus USA INC | $45.97 | 2023-2025 | Fluad, Flucelvax, Fluad Quadrivalent |
| Astellas Pharma US INC | $41.02 | 2023-2025 | Veozah |
| Pfizer INC. | $34.95 | 2024-2025 | |
| Glaxosmithkline, LLC. | $31.16 | 2023-2025 | Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $28.33 | 2024-2025 | Airsupra, Breztri |
| Sumitomo Pharma America, INC. | $21.51 | 2023 | Gemtesa |
| Exact Sciences Corporation | $17.57 | 2024 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.90 | 2025 | Jardiance |
| Dynavax Technologies Corporation | $15.25 | 2023 | Heplisav-B |
| Idorsia Pharmaceuticals US INC | $14.71 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Halley Donlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.